CTOs on the Move

Metabolic Solutions Development

www.msdrx.com

 
Metabolic Solutions Development Company, LLC (MSDC) discovers and develops novel molecular targets and new therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company has raised nearly $55 million in support of the development of its novel therapeutic drugs, MSDC-0160 and MSDC-0602, which selectively modulate mitochondrial control of to important cellular activities, such as carbohydrate, lipid, and amino acid metabolism, that are out of balance in patients with type 2 diabetes. Such imbalances may also play a role in other diseases of aging such as Alzheimer’s disease and Parkinson’s disease, as well ...
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million
  • www.msdrx.com
  • 161 E. Michigan Ave. 4th Floor
    Kalamazoo, MI USA 49007
  • Phone: 269.343.6732

Executives

Name Title Contact Details

Funding

Metabolic Solutions Development raised $16.1M on 09/25/2015

Similar Companies

Esschem

Esschem is the worlds most respected manufacturer of specialty acrylic polymers and monomers for medical and cosmetic uses.

Vical

Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases. The Company has three active independent

Sagent Pharmaceuticals

Sagent Pharmaceuticals is a Schaumburg, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fovioptics (Main)

Fovioptics (Main) is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.